Countries covered: Europe
Introduction:
The European facial injectable market-comprising revenues from the sale of botulinum toxin (BTX), hyaluronic acid (HA) dermal fillers, and particle and polymer filler (PPF) products sold in France, Germany, Italy, Spain and the UK-emerged out of the economic recession and posted modest growth from 2009 to 2010. With economic conditions beginning to improve, aesthetically conscious Europeans who had postponed or canceled cosmetic procedures were prompted to receive treatment, particularly as manufacturers made attempts to generate sales through heavy discounts and other efforts. Through 2015, market gains will accelerate as disposable incomes increase and consumer demand-among women and men-climbs for antiaging treatments and cosmetic enhancements that improve career prospects. The market was also boosted by greater product availability, such as Ipsen's Azzalure and Merz Pharma's BOCOUTURE. The combined use of multiple facial injectable products to treat the entire face and in conjunction with plastic surgery to achieve superior aesthetic results will also drive unit sales, thereby offsetting average selling prices (ASPs) declines due to price competition. ASPs will, however, stabilize as the markets recover from the downturn and as more premium products become available. Overall, this combination of factors will lead to robust growth in the European facial injectable market through 2015.
Questions Answered in This Report:
- In Europe, the facial injectable market suffered greatly during the global recession in 2008 and 2009. By 2010, however, the market showed signs of strong recovery. What are the factors that are driving this upturn? How will market recovery and growth differ across the countries covered in this report?
- Aesthetic surgeons in Europe are increasingly offering BTX and dermal filler treatments in combination with each other, as well as in conjunction with other cosmetic procedures to enhance the aesthetic results and the duration of the cosmetic effects of these procedures. To what extent will the trend toward combination treatments affect sales of facial injectable products? What are competitors doing to capitalize on this trend? Which of the competitors are well positioned to benefit from the rising popularity of combination treatments?
- The patient demographic for facial injectable procedures is expanding, with a rising number of younger women and men of all ages looking into undergoing these procedures. What is driving these new patient types to undergo facial injectable treatments? In which countries is this trend more prominent? How will this affect market growth?
- The launch and adoption of Ipsen's Azzalure, which comes in a much smaller vial size compared to Dysport, resulted in a significant change in unit sales for 2010. How did the switch from 500-unit to 125-unit vial sizes impact BTX sales in each of the countries? In which countries is Azzalure being more rapidly adopted? What effect did the uptake of Azzalure have on ASPs, and what was the net effect on market growth?
Scope:
Regions covered: Europe (France, Germany, Italy, Spain, UK)
Procedure and market segmentation: Our analysis uses the following breakdown of procedures and the market:
- BTX
- Dermal fillers
- HA dermal fillers
- PPFs
Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period (2009-2015).
Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.
|
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 EUROPEAN FACIAL INJECTABLE MARKET
- 1.1 Market Overview
- 1.2 Market Analysis
- 1.2.1 Key Report Updates
- 1.2.2 Product Overview
- 1.2.3 Market Definition
- 1.2.4 Procedures
- 1.2.5 Market Forecast
- 1.2.5.1 French Facial Injectable Market
- 1.2.5.2 German Facial Injectable Market
- 1.2.5.3 Italian Facial Injectable Market
- 1.2.5.4 Spanish Facial Injectable Market
- 1.2.5.5 UK Facial Injectable Market
- 1.2.6 Market Drivers and Limiters
- 1.2.6.1 Market Drivers
- 1.2.6.2 Market Limiters
- 1.3 Competitive Analysis
- 1.3.1 Competitive Landscape
- 1.3.2 Market Shares
- 1.3.3 Competitor Discussions (in Alphabetical Order)
- Allergan
- Ipsen (through distributor Galderma)
- Laboratoires TEOXANE
- Merz Pharma (including BioForm Medical)
- Q-Med
- Other
- 2.0 BOTULINUM TOXIN MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Product Overview
- 2.2.2 Market Forecast
- 2.2.3 Market Drivers and Limiters
- 2.2.3.1 Market Drivers
- 2.2.3.2 Market Limiters
- 2.3 Competitive Analysis
- 2.3.1 Competitive Landscape
- 2.3.2 Market Shares
- 3.0 DERMAL FILLER MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Product Overview
- 3.2.1.1 Hyaluronic Acid Fillers
- Standard Hyaluronic Acid Dermal Fillers
- Rejuvenation Hyaluronic Acid Dermal Fillers
- 3.2.1.2 Particle and Polymer Fillers
- 3.2.2 Market Forecast
- 3.2.2.1 Hyaluronic Acid Filler Market
- 3.2.2.2 Particle and Polymer Filler Market
- 3.2.3 Market Drivers and Limiters
- 3.2.3.1 Market Drivers
- 3.2.3.2 Market Limiters
- 3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.1.1 Hyaluronic Acid Filler Market
- 3.3.1.2 Particle and Polymer Filler Market
- 3.3.2 Market Shares
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- APPENDIX B: SUPPLEMENTAL FIGURES
- LIST OF FIGURES AND TABLES
- EXECUTIVE SUMMARY
- Figure 1: Facial Injectable Market, by Segment, Europe (US$), 2009-2015
- Figure 2: BTX Market, by Country, Europe (US$), 2009-2015
- Figure 3: Dermal Filler Market, by Segment, as a % of Total, Europe, 2010 and 2015
- Table 1: Companies Mentioned in This Report
- METHODOLOGY
- Table 2: Average Currency Exchange Rates, 2010
- 1.0 EUROPEAN FACIAL INJECTABLE MARKET
- Figure 4: Facial Injectable Market, by Segment, Europe (US$), 2009-2015
- Table 3: Key Report Updates, 2011
- Table 4: Common Facial Injectable Products, Europe, 2010
- Table 5: Common Facial Injectable Indications, by Type, Europe, 2010
- Table 6: Volume of Facial Injectable Product per Procedure, by Product
- Table 7: Facial Injectable Procedures, by Segment, Europe, 2009-2015
- Table 8: Facial Injectable Procedures, by Country, Europe, 2009-2015
- Table 9: BTX Procedures, by Country, Europe, 2009-2015
- Table 10: Dermal Filler Procedures, by Country, Europe, 2009-2015
- Table 11: HA Dermal Filler Procedures, by Country, Europe, 2009-2015
- Table 12: PPF Procedures, by Country, Europe, 2009-2015
- Figure 5: Facial Injectable Market, by Country, Europe (US$), 2009-2015
- Table 13: Facial Injectable Market, by Segment, Europe (US$), 2009-2015
- Table 14: Facial Injectable Market, by Segment, Europe (€), 2009-2015
- Table 15: Facial Injectable Market Growth, by Segment, Europe, 2010-2015
- Table 16: Facial Injectable Market, by Segment, as a % of Total, Europe, 2009-2015
- Table 17: Facial Injectable Market, by Country, Europe (US$), 2009-2015
- Table 18: Facial Injectable Market, by Country, Europe (€ and £), 2009-2015
- Table 19: Facial Injectable Market Growth, by Country, Europe, 2009-2015
- Table 20: Facial Injectable Market, by Country, as a % of Total, Europe 2009-2015
- Table 21: Drivers and Limiters of the Facial Injectable Market, Europe
- Figure 6: Leading Competitors in the Facial Injectable Market, as a % of Total, Europe, 2010
- Table 22: Leading Competitors in the Facial Injectable Market, by Segment, as a % of Total, Europe, 2010
- 2.0 BOTULINUM TOXIN MARKET
- Figure 7: BTX Market, by Country, Europe (US$), 2009-2015
- Table 23: Common Cosmetic BTX Products, Europe, 2010
- Table 24: BTX Market, by Country, Europe (US$), 2009-2015
- Table 25: BTX Market, by Country, Europe (€ and £), 2009-2015
- Table 26: BTX Market Growth, by Country, Europe, 2009-2015
- Table 27: BTX Market, by Country, as a % of Total, Europe, 2009-2015
- Table 28: Drivers and Limiters of the BTX Market, Europe
- Table 29: Leading Competitors in the BTX Market, by Country, as a % of Total, Europe, 2010
- 3.0 DERMAL FILLER MARKET
- Figure 8: Dermal Filler Market, by Country, Europe (US$), 2009-2015
- Table 30: Common HA Dermal Filler Products, Europe, 2010
- Table 31: Common PPF Products, Europe, 2010
- Table 32: Dermal Filler Market, by Segment, Europe (US$), 2009-2015
- Table 33: Dermal Filler Market, by Segment, Europe (€), 2009-2015
- Table 34: Dermal Filler Market, by Country and Segment, Europe (US$), 2009-2015
- Table 35: Dermal Filler Market, by Country and Segment, Europe (€ and £), 2009-2015
- Table 36: Dermal Filler Market Growth, by Segment, Europe, 2010-2015
- Table 37: Dermal Filler Market, by Segment, as a % of Total, Europe, 2009-2015
- Table 38: HA Dermal Filler Market, by Country, Europe (US$), 2009-2015
- Table 39: HA Dermal Filler Market, by Country, Europe (€ and £), 2009-2015
- Table 40: HA Dermal Filler Market Growth, by Country, Europe, 2010-2015
- Table 41: HA Dermal Filler Market, by Country, as a % of Total, Europe, 2009-2015
- Table 42: PPF Market, by Country, Europe (US$), 2009-2015
- Table 43: PPF Market, by Country, Europe (€ and £), 2009-2015
- Table 44: PPF Market Growth, by Country, Europe, 2010-2015
- Table 45: PPF Market, by Country, as a % of Total, Europe, 2009-2015
- Table 46: Drivers and Limiters of the Dermal Filler Market, Europe
- Table 47: Leading Competitors in the Dermal Filler Market, by Segment, as a % of Total, Europe, 2010
- Table 48: Leading Competitors in the HA Dermal Filler Market, by Country, as a % of Total, Europe, 2010
- Table 49: Leading Competitors in the PPF Market, by Country, as a % of Total, Europe, 2010
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
- APPENDIX B: SUPPLEMENTAL FIGURES
- Figure 9: Facial Injectable Market, by Segment, Europe (US$), 2009-2015 (Detailed Format)
- Figure 10: BTX Market, by Country, Europe (US$), 2009-2015 (Detailed Format)
- Figure 11: Dermal Filler Market, by Segment, as a % of Total, Europe, 2010 and 2015 (Detailed Format)
More Europe Dermatology Reports
Medicated Skin Care in Denmark by
Euromonitor International
Medicated skin care grew by 1% in 2011 to reach sales of DKr144 million. The positive growth stemmed from consumers’ increasing willingness to self-medicate and ...
Medicated Skin Care in Spain by
Euromonitor International
Like the rest of the Spanish OTC market, sales of medicated skin care have been negatively influenced by the poor economic environment. However, the fact ...
Medicated Skin Care in Hungary by
Euromonitor International
Medicated skin care continues to be negatively impacted by the economic crisis and the fact that many Hungarian consumers are spending less on non-essential products. ...
Medicated Skin Care in Portugal by
Euromonitor International
Competition between medicated skin care and cosmetic products intensified in 2010 as consumer purchasing declined and cosmetics manufacturers increasingly positioned their brands as alternative treatments ...
Medicated Skin Care in Poland by
Euromonitor International
In 2010 a number of product areas in medicated skin care were still associated with embarrassment amongst consumers. Whilst the taboos surrounding vaginal or skin ...
See all reports like this >>
More Europe Reports
A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
See all reports like this >>
Share this report
Other tasks Related Markets Dermatology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
